Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MANE

Veradermics Inc

May 29 • 04:00PM ET

100.91

-1.97 -1.91 %

Healthcare • Biotechnology • USA • Mid • NYSE

Peers: ORKA KRYS RYTM BMRN VKTX ALNY INCY AXSM MDGL NBIX

| Held by: VTI VXF SCHA JGRO LFSC TOS ITOT FPX SCHB VTWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	28.44%	Shs Outstand	37.34M	Perf Week	-3.62%
Market Cap	4.22B	Forward P/E	-	EPS next Y	-2.58	Insider Trans	31.47%	Shs Float	29.90M	Perf Month	-5.29%
Enterprise Value	3.83B	PEG	-	EPS next Q	-0.67	Inst Own	51.84%	Short Float	6.86%	Perf Quarter	120.09%
Income	-	P/S	-	EPS this Y	13.11%	Inst Trans	114.77%	Short Ratio	3.77	Perf Half Y	-
Sales	-	P/B	9.62	EPS next Y	12.51%	ROA	-	Short Interest	2.05M	Perf YTD	167.31%
Book/sh	10.49	P/C	10.79	EPS next 5Y	26.34%	ROE	-	52W High	117.71 -14.27%	Perf Year	-
Cash/sh	9.35	P/FCF	-	EPS past 3/5Y	-117.94% -	ROIC	-	52W Low	32.00 215.34%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.42% 7.66%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	7.64	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	59.12	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.72	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	59.12	EPS Q/Q	-	SMA20	-3.36%	Beta	-	Target Price	131.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	19.47%	Rel Volume	2.19	Prev Close	102.88
Employees	21	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	43.48%	Avg Volume	544.21K	Price	100.91
IPO	Feb 04, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	-70.56% -	Trades		Volume	1,189,553	Change	-1.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)